Background to methamphetamine reclassification
· Ministerial Action Group on Alcohol and
Drugs
·
· Background to methamphetamine
reclassification
·
· The proposal is
that:
·
· methamphetamine be re-classified in the
First Schedule (Class A) and that a presumption for supply
be set at 5 grams of pure methamphetamine; that
methcathinone be classified in the First Part of the Second
Schedule (Class B1); that 4-MTA be classified in the Second
Part of the Second Schedule (Class B2); and that pemoline
and aminorex be classified in the Fifth Part of the Third
Schedule (Class C5) of the Act.
·
· These proposed
classifications and re-classification reflect the potential
risk of harm associated with these substances and is
consistent with New Zealand’s international obligations
under the United Nations drug classification framework.
·
· There will also be complementary initiatives,
such as the provision of accurate health information and
harm minimisation messages to help reduce potential harm
from these substances.
·
· The reclassification and
other issues will be considered by the Health Select
Committee.
·
· The Misuse of Drugs Amendment Act 2000
·
· The Misuse of Drugs Amendment Act 2000 changed
the way controlled drugs are classified under New Zealand
law. A more efficient and evidence-based process was
designed, including the establishment of the EACD to help
assess the risk of harm that each drug poses. The harms the
EACD consider include:
·
· the likelihood or evidence
of drug abuse, including such matters as the prevalence of
the drug, levels of consumption, drug seizure trends and the
potential appeal to vulnerable populations; the specific
effects of the drug, including pharmacological, psychoactive
and toxicological effects; the risks to public health; the
potential for use of the drug to cause death; the ability of
the drug to create physical or psychological dependence.
·
· The EACD also considers if the drug has any
therapeutic use, the international classification and
experience of a drug and any other matters the Minister
considers relevant.
·
· The EACD membership comprises
experts in toxicology, pharmacology, community medicine,
psychology, drug treatment, pharmaceuticals, and public
health. The Police and the Customs Service sit on the EACD,
as does a consumer representative. Under the Act the EACD
reports to the Minister responsible for the National Drug
Policy.
·
· The Act now requires controlled drugs to
be classified according to the risk of harm to individuals
or society. Accordingly, drugs posing a:
·
· very
high risk of harm should be scheduled as Class A and hence
listed in the First Schedule to the Act high risk of harm
should be scheduled as Class B and hence listed in one of
the Parts in the Second Schedule to the Act moderate risk of
harm should be scheduled as Class C and hence listed in one
of the Parts to the Third Schedule to the
Act.
·
· Health harms
·
· Methamphetamine can
cause immediate death by causing strokes, convulsions, heart
attacks and liver necrosis amongst other
things.
·
· Many deaths associated with
methamphetamine use are caused by accident (59% in Taiwan)
and homicide (approx 28% in Osaka and 14% in
Taiwan).
·
· In New Zealand several deaths have been
associated with methamphetamine poisoning and heart attacks
or strokes associated with methamphetamine use. Police also
relate anecdotal evidence of violent deaths and homicides
either relating to the use or supply of
methamphetamine.
·
· In the US the number of
methamphetamine related deaths rose for 155 in 1991 to 433
in 1994. In Taiwan 244 methamphetamine related deaths were
noted between 1991 and 1996.
·
· Methamphetamine
harms are also associated with the production of
methamphetamine (toxic chemicals and potential explosions)
and the supply of methamphetamine (violence, criminality and
imprisonment).
·
· Psychological effects are severe,
especially if used continuously over a number of days. One
Australian user described a psychotic episode he had when,
after bingeing for several days, he hallucinated police
‘everywhere’, took out his unlicensed shotgun and sat on the
roof and, in his words, ‘if any one had walked up his
driveway they would have been
dead’.
·
· Environmental
·
· Clandestine
laboratories are dealing with toxic and dangerous chemicals
with none of the safety equipment or procedures that most
organisations dealing with such chemicals have. Safety is
not given a high priority, there is rarely proper
ventilation and often the ‘cooks’ dealing with these
chemicals do not have an understanding or knowledge of their
toxicity and the dangers associated with them.
·
· In
clandestine laboratories there are several unstable and
volatile chemicals and fire or explosion are serious
concerns. In the US most clandestine laboratories are
discovered due to fire and many have exploded, causing harm
and death to the people in the laboratory and also posing
harm to the neighbourhood.
·
· The clean up of
clandestine laboratories is an arduous and costly operation.
Decontamination of the site, and the people in it, can cost
up to $100,000 and more decontamination is required for the
site to be habitable again.
·
· The chemicals and
waste products from clandestine laboratories are disposed of
secretly and are often disposed of carelessly as a result.
Some disposal sites for these toxic chemicals have included
nearby streams or rivers, drains and between the cracks in
the floor of one particular laboratory.
·
· Social
costs
·
· Like other addictive drugs methamphetamine
has an impact on the family, local area and community.
Particular social costs that have been identified are family
breakdown, relationship problems and neglect of
children.
·
· The costs associated with
methamphetamine related psychosis, psychological disorders
and general cognitive damage and costs to family and
community of these conditions and their
treatment.
·
· Increased methamphetamine related
violent crime in communities. Anecdotal reports indicate
increases in domestic violence and violence towards
children.
·
· Some commentators and people in the
Alcohol and Drug sector have spoken of their fears of a
‘lost generation’ of methamphetamine users for who their
dependence and heavy use of methamphetamine has made them
socially dysfunctional, leading to many other social
problems that will need to be dealt with.
·
· Costs
to industry Pharmacists already have in place measures to
limit the purchase and/or theft of methamphetamine precursor
substances from their pharmacies. This adds to costs for
pharmacists.
·
· It was reported in the news on 11
December 2002 that pharmacists were concerned about
increased burglaries and had fears of armed robberies being
carried out for methamphetamine precursor substances.